home / stock / bmrn / bmrn articles
Dennis Slamon, Board Member at Biomarin Pharmaceutical (NASDAQ:BMRN), reported a large exercise of company stock options on March 20, according to ...
HENRY FUCHS, President at Biomarin Pharmaceutical (NASDAQ:BMRN), reported an insider sell on March 7, according to a new SEC filing. What Happened...
Activist investor Elliott Investment Management has taken a significant position in BioMarin Pharmaceutical Inc (NASDAQ: BMRN),...
In its Q3 earnings release, PTC Therapeutics Inc (NASDAQ: PTCT) reported a delay to the planned submission of sepiapterin in ph...
Raymond James initiated coverage on BioMarin Pharmaceuticals Inc (NASDAQ: BMRN) with a Market Perform rating, noting sparsity in&nbs...
News, Short Squeeze, Breakout and More Instantly...
BioMarin Pharmaceutical Inc. Company Name:
BMRN Stock Symbol:
NASDAQ Market:
BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET PR Newswire SAN RAFAEL, Calif. , April 10, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexand...
2024-04-10 03:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Dennis Slamon, Board Member at Biomarin Pharmaceutical (NASDAQ:BMRN), reported a large exercise of company stock options on March 20, according to ...